Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Corvas International Inc.

Division of Dendreon Corp.

Latest From Corvas International Inc.

Off With Their Heads

A number of recent management shake-ups, in the midst of biotech's deep depression, are an indication of the industry's desperation to find a solution to its stock market woes--as well as the exhaustion of leaders tired of trying to break through Wall Street's attention barriers.

BioPharmaceutical Leadership

Vascular Genomics Inc.

San Diego-based virtual start-up Vascular Genomics Inc. is leveraging its proteome research--specifically, proteomic maps of the human vascular endothelium--into therapeutic candidates.


Cor Therapeutics: Dealmaking for the Marketplace

Cor’s deal on Integrelin with Schering was the necessary keystone in its deal strategy but has also allowed the company to maintain momentum towards the marketplace despite the disappointing results of its Phase III trial.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dendreon Corp.
  • Senior Management
  • Randall E Woods, Pres. & CEO
    George P Vlasuk, PhD, EVP, R&D & CSO
    Stephen F Keane, VP, Corp. Dev.
    Carolyn M Felzer, VP, Controller
  • Contact Info
  • Corvas International Inc.
    Phone: (858) 455-9800
    3030 Science Park Rd.
    San Diego, CA 92121-1102